ANAPA BIOTECH A/S: Financial statements 2023
CVR: 27585167
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,693,656 and a net result of DKK 1,674,278 compared with DKK 76,011 the year before. That is an increase of 580.8% compared with the year before. Equity in the 2023 report amounted to DKK 2,834,556. The solvency ratio was 72%.
- Gross Profit
- DKK 1,693,656
- Profit/Loss
- DKK 1,674,278
- Equity
- DKK 2,834,556
- Total Assets
- DKK 3,935,112
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.7M | 1.7M | 2.8M | - |
| 2022 | - | 249K | 76K | 1.2M | - |
| 2021 | - | 1M | 612K | 1.1M | - |
| 2020 | - | 526K | 472K | 472K | 1 |
| 2019 | - | 104K | -3.8M | 0 | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ANAPA BIOTECH A/S has published its annual report for 2022. Gross profit came to DKK 248,788, and the net result was DKK 76,011.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.
